Comparative Analysis of Long-Standing and Newly Diagnosed Diabetes Mellitus in Patients with Pancreatic Ductal Adenocarcinoma: A Tunisian Multicenter Study

##plugins.themes.academic_pro.article.sidebar##

Published Jan 2, 2025
https://doi.org/10.62438/tunismed.v103i1.5328
Download
pdf
Vol. 103 No. 1 (2025): Tunis Med Jan 2025

##plugins.themes.academic_pro.article.main##

Hamza Elfekih
Department of Endocrinology Diabetology, Farhat Hached University Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia
Yasmine Charfeddine
Department of Family and Community Medicine, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
Mohamed Amine Said
Department of Surgery, Sahloul University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Wiem Saafi
Department of Endocrinology Diabetology, Farhat Hached University Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia
Hanen Jaziri
Department of Gastroenterology, Sahloul University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Mohamed Hedi Mraidha
Department of Surgery, Farhat Hached University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Imen Halloul
Department of Endocrinology Diabetology, Farhat Hached University Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia
Azer Ben Ali
Department of Surgery, Sahloul University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Sarra Yacoub
Department of Pathology, Farhat Hached University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Salem Brahem
Department of Radiology, Farhat Hached University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Ayoub Guesmi
Department of Radiology, Farhat Hached University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Mehdi Ksiaa
Department of Gastroenterology, Sahloul University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Slim Ben Ahmed
Department of Medical Oncology, Farhat Hached University Hospital, Sousse. Faculty of Medicine of Sousse, University of Sousse, Tunisia
Jihen Sahli
Department of Family and Community Medicine, Faculty of Medicine of Sousse, University of Sousse, Tunisia
Ghada Saad
Department of Endocrinology Diabetology, Farhat Hached University Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia
Yosra Hasni
Department of Endocrinology Diabetology, Farhat Hached University Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia

Abstract

Introduction: Diabetes mellitus has emerged as a global public health issue due to its increasing prevalence and the increased risk of developing cancers. Pancreatic cancer is believed to be both a consequence of pre-existing diabetes and a potential cause of new-onset diabetes.


Aim: This study aims to compare the characteristics of patients with pancreatic ductal adenocarcinoma and newly diagnosed or long-standing diabetes mellitus.


Methods: A multicentric retrospective study was conducted over 13 years at two university hospitals in Sousse, Tunisia. Included patients had whether a newly diagnosed or a long-standing diabetes mellitus with histologically confirmed pancreatic ductal adenocarcinoma. Statistical analysis using appropriate tests was conducted.


Results: The prevalence of diabetes mellitus was 44.6% among three hundred and seven patients with pancreatic cancer. The male-to-female ratio in patients with pancreatic ductal adenocarcinoma was 2.6:1. Patients’ mean age was 63.9 years, with the majority being over 50 years old. Most patients had no family history of diabetes and exhibited significant weight loss, low body mass index, and uncontrolled diabetes. The comparison between individuals with newly diagnosed diabetes and those with long-standing diabetes revealed numerous similarities, apart from significant differences in drinking patterns (p = 0.03), tumor size (p = 0.018), and smoking in the subgroup of males (p = 0.044).


Conclusion: Patients over 50 with newly diagnosed diabetes mellitus, particularly those who consume alcohol occasionally and men who are not heavy smokers, should undergo further evaluation to identify potential early-stage pancreatic ductal adenocarcinoma

Keywords:

Diabetes mellitus, Pancreatic Neoplasms, Pancreatic ductal carcinoma, Smoking, Alcoholism

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Magliano DJ, Boyko EJ. IDF DIABETES ATLAS. IDF Diabetes Atlas. 10th ed. Brussels2021.
  2. Arredondo A, Azar A, Recaman AL. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America. Glob Public Health. 2018;13(7):780-7.
  3. Mbarki S, Ben Abdelaziz A, Ben Hassine D, Melki S, Ben Rejeb N, Omezzine A, et al. Epidemiology of diabetes mellitus in Tunisia. HSHS 2 study (Hammam Sousse Sahloul Heart Study). Tunis Med. 2022;100(3):229-40.
  4. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.
  5. Gallo M, Adinolfi V, Morviducci L, Acquati S, Tuveri E, Ferrari P, et al. Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Societa Italiana Endocrinologia (SIE)/Societa Italiana Farmacologia (SIF) multidisciplinary consensus position paper. ESMO Open. 2021;6(3):100155.
  6. Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493-502.
  7. El Guesmi S, Ben Nasr S, Afrit M, Labidi S, Boussen H. Exocrine Pancreatic carcinoma in Tunisia: A retrospective study about 158 cases. Tunis Med. 2015;93(2):73-5.
  8. Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298-321.
  9. Duan X, Wang W, Pan Q, Guo L. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development. Front Oncol. 2021;11:730038.
  10. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19-S40.
  11. Amri F, Belkhayat C, Yeznasni A, Koulali H, Jabi R, Zazour A, et al. Association between pancreatic cancer and diabetes: insights from a retrospective cohort study. BMC Cancer. 2023;23(1):856.
  12. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134(4):981-7.
  13. Souza JJ, Machado MC, Cunha JE, Jukemura J, Nery M, Wajchenberg BL, et al. Analysis of pancreatic adenocarcinoma tumor staging and resection according to previous body mass index and diabetes duration. Pancreatology. 2007;7(2-3):187-93.
  14. Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005;129(2):504-11.
  15. Moulin K, Gastaldi G, Serratrice J, Baroz F. Diabète et cancer du pancréas. Quand le diabète est annonciateur de cancer pancréatique. Revue Médicale Suisse. 2022;18(801):1994-8.
  16. Mellenthin C, Balaban VD, Dugic A, Cullati S. Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022;14(19).
  17. Tseng CH. New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer. Pancreas. 2013;42(1):42-8.
  18. Munigala S, Singh A, Gelrud A, Agarwal B. Predictors for Pancreatic Cancer Diagnosis Following New-Onset Diabetes Mellitus. Clin Transl Gastroenterol. 2015;6(10):e118.
  19. Sah RP, Nagpal SJ, Mukhopadhyay D, Chari ST. New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol. 2013;10(7):423-33.
  20. Hart PA, Kamada P, Rabe KG, Srinivasan S, Basu A, Aggarwal G, et al. Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas. 2011;40(5):768-72.
  21. Choe JW, Kim HJ, Kim JS, Cha J, Joo MK, Lee BJ, et al. Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes. Hepatobiliary Pancreat Dis Int. 2018;17(3):263-8.